Anne-Marie Cleton-Jansen

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 5

Top Topics

Postmenopausal Women

Bone Regeneration

Top Venues

Cancer immunology, immunotherapy : CII

Laboratory investigation; a journal of technical methods and pathology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sheena Li Ming Ong, Isadora Pereira Gomes, Hans Jacobus Baelde, Fabricio Passador-Santos, Bruno A B de Andrade, Inge H Briaire-de Bruijn, Israel L Cavalcante, Willem H Schreuder, Anne-Marie Cleton-Jansen, Arjen H G Cleven, Károly Szuhai, Carolina C Gomes, Judith V M G Bovée
No NFATC2 fusion in simple bone cyst of the jaw. Histopathology (2023)
Natasja Franceschini, Jan Oosting, Maud Tamsma, Bertine Niessen, Inge Briaire-de Bruijn, Brendy van den Akker, Alwine B Kruisselbrink, Ieva Palubeckaitė, Judith V M G Bovée, Anne-Marie Cleton-Jansen
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression. International journal of molecular sciences 22 (12) (2021)
Suk Wai Lam, Inge H Briaire-de Bruijn, J Tom van Wezel, Arjen H G Cleven, Pancras C W Hogendoorn, Anne-Marie Cleton-Jansen, Judith V M G Bovée
NTRK fusions are extremely rare in bone tumours. Histopathology 79 (5) (2021)
Natasja Franceschini, Raffaele Gaeta, Paul Krimpenfort, Inge H Briaire-de Bruijn, Alwine B Kruisselbrink, Károly Szuhai, Ieva Palubeckaitė, Anne-Marie Cleton-Jansen, Judith V M G Bovée
A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target. Laboratory investigation; a journal of technical methods and pathology 102 (4) (2021)
Yayan T Sundara, Marie Kostine, Arjen H G Cleven, Judith V M G Bovée, Marco W Schilham, Anne-Marie Cleton-Jansen
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy. Cancer immunology, immunotherapy : CII 66 (1) (2016)